The founders say COVID laboratory demand fell sharply in 2022, causing a loss of product-market fit and forcing Dashlabs to operate lean and pivot from COVID lab software toward broader diagnostic clinics and laboratories.
SourceSoftware for medical laboratories and clinics
Public company, workplace, funding, and market signals
Dashlabs.ai is a Y Combinator W21 healthcare SaaS company building an end-to-end clinic and laboratory management platform for diagnostic labs, medical centers, hospitals, and related healthcare operators across Southeast Asia. It digitizes intake, results encoding, machine integrations, billing, reporting, and workflows in one system.
Primary product
End-to-end clinic management / laboratory information system (LIS) for healthcare operations
Founded
2020
Headquarters
29F Summit One Tower, 530 Shaw Blvd., Mandaluyong City, Philippines
Team size
30-40 employees
Work style
Flexible
Industry
Technology, Information and Internet
Sub-industry
Healthcare IT / laboratory information systems
0 jobs at Dashlabs.ai
Check back later for new openings
Offices
Business model
Stage
Seed
Total raised
$1.4M
Latest round
Seed Round · Nov 2021
Latest amount
$1.3M
Leadership
CEO / CTO
Chief Operating Officer / Co-Founder
CFO / Co-Founder
Co-Founder
Co-Founder
Country Head (PH) - Sales and Business Ops
Product Design Lead
Country Head
Investors
Mission-driven, customer-feedback-driven, and remote-first/flexible. Public materials emphasize collaboration, empowerment, a diverse and friendly team, and a healthcare mission framed as improving access to quality diagnostics.
Work style
Flexible
Compensation
Public job postings say non-intern roles offer competitive compensation, while at least one internship posting is explicitly unpaid. No broader public compensation bands were found.
Pricing
Tiered SaaS: free tier, per-branch base subscription, optional add-on modules, and sales-led enterprise/custom pricing
Differentiators
Technology
Customers
Competitors
Estimated revenue
Approx. USD 4.1M-5.1M ARR (public estimates)
Estimated monthly visits
2.7K
Traffic estimate as of Jun 2026
The founders say COVID laboratory demand fell sharply in 2022, causing a loss of product-market fit and forcing Dashlabs to operate lean and pivot from COVID lab software toward broader diagnostic clinics and laboratories.
SourceDashlabs.ai / Medium · May 2026
Founder story describing the company’s pivot from COVID-era volunteer project to healthcare SaaS, the product-market-fit collapse after COVID testing demand fell, and growth to 350+ facilities and 20M+ patients processed.
Dashlabs.ai / Medium · Mar 2026
Explains the product scope, target markets, pricing approach, and customer segments, including diagnostic clinics, laboratories, hospitals, and secondary use cases such as fertility, vet, beauty, and corporate clinics.
BusinessWorld Online · Sep 2024
Profile piece on Dashlabs.ai’s AI-enabled lab automation, customer rollout, and pricing. CEO Weston Coleman Lim says clinics using Dashlabs can cut processing time from 7-14 days to 24-48 hours for large batches.
BusinessWorld Online · Jan 2023
Coverage of a multistakeholder collaboration involving ICanServe Foundation, Taguig City, Dashlabs.ai, and Novartis to support breast cancer control program data work.
Manila Bulletin · Feb 2022
Reports Dashlabs.ai’s seed funding announcement in 2022, naming ADB Ventures, Summit Media CEO/JG Summit Digital Transformation, Good News Ventures, Immeasurable, and other investors.